Metrizamide cisternography with hypocycloidal tomography: preliminary results

Area of Science:

• Radiology
• Neuroradiology
• Medical Imaging

Background:

• Metrizamide (Amipaque) is a nonionic, water-soluble contrast agent.
• It has been evaluated for diagnostic imaging of the central nervous system.

Purpose of the Study:

• To assess the safety and efficacy of metrizamide for myelography.
• To present preliminary results of metrizamide cisternography with hypocycloidal tomography.

Main Methods:

• Clinical trials involving lumbar, cervical, thoracic, and intracranial examinations using metrizamide.
• Metrizamide cisternography combined with hypocycloidal tomography.

Main Results:

• Metrizamide demonstrated safety and efficacy in lumbar myelography.
• Good results were obtained in cervical, thoracic, and intracranial examinations.
• Significant complications were rare, and patient tolerance was remarkably good.

Conclusions:

• Metrizamide is a safe and effective contrast agent for various myelographic examinations.
• The combination of metrizamide cisternography and hypocycloidal tomography provides excellent anatomical detail.